B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction

Journal of the American College of Cardiology

Volumn 61, Issue 14, 2013, Pages 1498-1506

  Van Veldhuisen, Dirk J ^a   Linssen, Gerard C M ^a   Jaarsma, Tiny ^b,c   Van Gilst, Wiek H ^a   Hoes, Arno W ^d   Tijssen, Jan G P ^a   Paulus, Walter J ^e   Voors, Adriaan A ^a   Hillege, Hans L ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LINKÖPING UNIVERSITY   (Sweden)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

heart failure; natriuretic peptides; preserved ejection fraction; prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADVERSE OUTCOME; AGED; CARDIAC PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NOTE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 84875766051     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.12.044     Document Type: Article

References (41)

1. J.J.V. McMurray, S. Adamopoulos, S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Eur J Heart Fail 14 2012 803 869
2. M. Kindermann, J.C. Reil, B. Pieske, D.J. Van Veldhuisen, M. Böhm Heart failure with normal left ventricular ejection fraction: what is the evidence Trends Cardiovasc Med 18 2008 280 292
3. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
4. R.S. Bhatia, J.V. Tu, D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
5. W.J. Paulus, J.J. Van Ballegoij Treatment of heart failure with normal ejection fraction: an inconvenient truth J Am Coll Cardiol 55 2010 526 537
6. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, C.K. Reiss, D. Levy Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort J Am Coll Cardiol 33 1999 1948 1955
7. H. Krum, W.T. Abraham Heart failure Lancet 373 2009 941 955
8. D.J. Holland, D.J. Kumbhani, S.H. Ahmed, T.H. Marwick Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction: a meta-analysis J Am Coll Cardiol 57 2011 1676 1686
9. S. Ather, W. Chan, B. Bozkurt Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
10. L. Caruana, M.C. Petrie, A.P. Davie, J.J. McMurray Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study BMJ 321 2000 215 218
11. M.T. Maeder, D.M. Kaye Heart failure with normal left ventricular ejection fraction J Am Coll Cardiol 53 2009 905 918
12. H. Persson, E. Lonn, M. Edner CHARMES Investigators Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy - CHARMES J Am Coll Cardiol 49 2007 687 694
13. L.B. Daniels, A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
14. J.L. Januzzi Jr., S.U. Rehman, A.A. Mohammed Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular dysfunction J Am Coll Cardiol 58 2011 1881 1889
15. N. Parekh, A.S. Maisel Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure Curr Opin Cardiol 24 2009 155 160
16. M. Komajda, P.E. Carson, S. Hetzel Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE) Circ Heart Fail 4 2011 27 35
17. T. Jaarsma, M.H. Van der Wal, J. Hogenhuis Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure Eur J Heart Fail 6 2004 227 233
18. T. Jaarsma, M.H. Van der Wal, I. Lesman-Leegte COACH Investigators Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Arch Intern Med 168 2008 316 324
19. J. Hogenhuis, A.A. Voors, T. Jaarsma Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP in patients with heart failure Eur J Heart Fail 9 2007 787 794
20. T. Jaarsma, I. Lesman-Leegte, H.L. Hillege, N.J. Veeger, R. Sanderman, D.J. Van Veldhuisen Depression and the usefulness of a disease management program in heart failure: insights from the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) study J Am Coll Cardiol 55 2010 1837 1843
21. P. Royston, G. Ambler, W. Sauerbrei The use of fractional polynomials to model continuous risk variables in epidemiology Int J Epidemiol 28 1999 964 974
22. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC CPG ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Eur Heart J 29 2008 2388-42
23. P.M. Grambsch, T.M. Therneau Proportional hazards test and diagnosis based on weighted residuals Biometrika 81 1994 515 526
24. A.S. Maisel, J. McCord, R.M. Nowak Breathing Not Properly Multinational Study Investigators Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly Multinational Study J Am Coll Cardiol 41 2003 2010 2017
25. F. Bursi, S.A. Weston, M.M. Redfield Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
26. G.C. Fonarow, W.F. Peacock, C.O. Phillips ADHERE Scientific Advisory Committee and Investigators Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
27. C.R. DeFilippi, R.H. Christensen, W.J. Kop, J.S. Gottdiener, M. Zhan, S.L. Selinger Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death? J Am Coll Cardiol 58 2011 1497 1506
28. D. Postmus, D.J. Van Veldhuisen, T. Jaarsma The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure Eur J Heart Fail 14 2012 168 175
29. K. Hogg, K. Swedberg, J. McMurray Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis J Am Coll Cardiol 43 2004 317 327
30. C. Franssen, W.J. Paulus The future diagnosis of heart failure with normal ejection fraction: less imaging, more biomarkers? Eur J Heart Fail 13 2011 1043 1045
31. C.S. Lam, E. Donal, E. Kraigher-Krainer, R.S. Vasan Epidemiology and clinical course of heart failure with preserved ejection fraction Eur J Heart Fail 13 2011 18 28
32. J.G. Cleland, M. Tendera, J. Adamus PEP-CHF Investigators The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
33. S. Yusuf, M.A. Pfeffer, K. Swedberg CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
34. D.J. van Veldhuisen, A. Cohen-Solal, M. Böhm SENIORS Investigators Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J Am Coll Cardiol 53 2009 2150 2158
35. M. Jessup, W.T. Abraham, D.E. Casey 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 119 2009 1977 2016
36. B.M. Massie, P.E. Carson, J.J. McMurray I-PRESERVE Investigators Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
37. I.S. Anand, T.S. Rector, J.G. Cleland Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial Circ Heart Fail 4 2011 569 577
38. S.D. Solomon, M.R. Zile, B. Pieske PARAMOUNT Investigators The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial Lancet 380 2012 1387 1395
39. J. Grewal, R. McKelvie, E. Lonn BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction Eur J Heart Fail 10 2008 252 259
40. E. Lubien, A. DeMaria, P. Krishnaswamy Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 105 2002 595 601
41. M. O'Donoghue, A. Chen, A.L. Baggish The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department J Card Fail 11 2005 S9 S14